This call was announced a month ago and there was no significant new info provided. Nothing on uplist GNBT / list NGIO, nothing on when we can expect a approved vaccine, nothing on the $5MM... and when I say nothing I mean concrete. Just a bunch of vagaries and quiet periods.
Why have a call today. They should have 1) not announced the call a month ago expecting to have info. 2) waited until either the S1s are approved or they have results and are ready for trials (and have a time frame when they will take next step)
Anything else, like mice could have been in a PR.
(6)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links